Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers
A Phase 3 Randomized Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (EU)
Sponsor: Healthpoint
Terminated
based on outcome of trial NCT01656889.
Other terminated trials from Healthpoint
Other Ulcer trials with similar outcome
Listed as NCT01853384, this PHASE3 trial focuses on Ulcer and Venous Stasis Ulcer and remains terminated or withdrawn. Sponsored by Healthpoint, it has been updated 7 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE3
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Healthpoint
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Anderlecht, Belgium , Bochum, Germany , Bonn, Germany , Brno, Czechia , Brussels, Belgium , Budapest, Hungary , Cologne, Germany , Debrecen, Hungary , Dresden, Germany , Düsseldorf, Germany and 36 more locations